Center for Medical Weight Loss (CMWL) review

What it is

CMWL started about 20 years ago as a network of in-person, physician-led weight-loss clinics and says it has served hundreds of thousands of members and worked with more than 200 physicians across 23 states. Its online program, run from Tarrytown, New York, offers compounded semaglutide and tirzepatide by weekly injection, plus lower-dose microdosing plans for maintenance. Its chief medical officer is listed as Kevin Jovanovic, MD. Members also get free access to CMWL Reset, an online behavioral and lifestyle course, and the company sells meal-replacement shakes and bars separately. It says it ships to all 50 states, with some options unavailable in certain states. Prescribing is done by independent licensed providers, and prescriptions are filled by a pharmacy licensed in your state.

How it works

You take a five-minute online quiz about your health history and choose a medication and plan. A board-certified physician in your state reviews your intake, checks your BMI (generally 26 or higher) and screens for conditions that rule out GLP-1s, such as a personal or family history of medullary thyroid cancer or MEN-2, pregnancy or active cancer treatment. If you're cleared, the physician writes your first prescription and a starting dose, and a licensed compounding pharmacy prepares and ships it, temperature-controlled where needed. From there you get 24/7 chat access to a provider and refill consultations, and your care team adjusts your plan as you go. Starter doses are only for people who haven't taken a GLP-1 in the past four weeks, and nothing is charged until a physician approves you.

Pricing transparency

Every plan includes the medication, physician care, unlimited messaging, membership and shipping, and the price stays the same at any dose. Compounded semaglutide is $149 billed monthly, $298 every three months ($99 a month, with the third month free) or $894 a year ($74 a month). Compounded tirzepatide is $239 monthly, $478 every three months ($159 a month) or $1,434 a year ($119 a month). Microdosing plans start at $83 a month for semaglutide and $116 for tirzepatide, with a three-month minimum. Three-month supplies are billed every 10 weeks so you don't run out. You're not charged if a clinician decides you don't qualify. Refunds otherwise apply in limited cases, and if you cancel an order after your intake has gone to a provider, you get the order amount back minus $50, but only if you ask the same day. HSA and FSA cards may be used.

Branded vs compounded

CMWL prescribes compounded semaglutide and compounded tirzepatide, which can include B vitamins or glycine to ease side effects. It explains that it uses compounding to allow more personalized dosing schedules, and it states that compounded drugs aren't FDA-approved or evaluated by the FDA for safety, effectiveness or quality. It doesn't name its pharmacy partners, saying only that they are LegitScript-certified, and it doesn't display a seal number of its own, so that certification isn't counted here. Its weight-loss calculator cites up to 20% weight loss from clinical trials, figures that come from the brand-name drugs rather than the compounded versions. Brand-name Wegovy or Zepbound isn't part of the online program. Its FAQ is candid that GLP-1s work better alongside changes in protein intake and strength training to protect muscle, and it points members to the Reset course for that. A search of the FDA warning-letter database under the CMWL and Center for Medical Weight Loss names returned no letters.

Pros and watch-outs

The evidence behind what Center for Medical Weight Loss (CMWL) prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How Center for Medical Weight Loss (CMWL) compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Willow

  Buyers who want every dose priced and the pharmacies named, and will pay more for it

  See Willow →
• Eden

  Compounded or branded GLP-1 through one consumer telehealth account

  See Eden →
• JumpstartMD

  California residents who want a structured, coach-heavy program with labs and body-composition tracking, in a clinic or online

  See JumpstartMD →

More GLP-1 telehealth reviews: New Wave Health · Eviora MD · Hers · Midi Health · Remedy Meds · OrderlyMeds